Reference values and hematologic changes from birth to 5 years in patients with sickle cell disease. Cooperative Study of Sickle Cell Disease
- PMID: 7519102
- DOI: 10.1001/archpedi.1994.02170080026005
Reference values and hematologic changes from birth to 5 years in patients with sickle cell disease. Cooperative Study of Sickle Cell Disease
Abstract
Objective: To examine hematologic changes from birth to 5 years of age and establish hematologic reference values for infants and children with sickle cell disease.
Research design: Prospective natural history study.
Setting: Nineteen pediatric sickle cell centers across the United States.
Patients: Six hundred ninety-four infants with sickle cell disease (sickle cell anemia, sickle cell-hemoglobin C disease, and sickle-beta-thalassemia) who were enrolled in the Cooperative Study of Sickle Cell Disease at younger than 6 months of age. Median follow-up time through 5 years of age was 4.1 years.
Measurements and results: We present longitudinal analyses of total hemoglobin concentration, percent fetal hemoglobin values, mean corpuscular volumes, total bilirubin concentration, and red blood cell (RBC), "pocked" RBC, white blood cell, platelet, and reticulocyte counts. Anemia was apparent by 10 weeks of life in infants with sickle cell anemia (SS infants). This anemia was associated with a rising reticulocyte count consistent with a hemolytic process. The reticulocyte count of SS infants increased steadily, exceeding 12% at 5 years of age. The fetal hemoglobin concentration of SS infants declined more slowly than that of infants with sickle cell hemoglobin C disease (SC infants). Pocked RBC counts rose sharply after 6 months of age, and by 1 year, 28% of SS infants had abnormal counts, above 3.5%, indicating poor splenic function. At 3 years of age, 78% of SS patients and 32% of SC patients had abnormal pocked RBC counts. The SS patients with concurrent alpha-thalassemia had, after 6 months of age and throughout early childhood, a slightly higher mean total hemoglobin concentration and lower mean pocked RBC and reticulocyte counts than SS patients without alpha-thalassemia. The hematologic profile of SC infants more closely resembled that of normal black infants, but there was mild anemia (10.5 g/dL) and slightly elevated mean values for reticulocytes (3%) and fetal hemoglobin (3%) during early childhood.
Similar articles
-
Effects of alpha-thalassemia-2 on the developmental changes of hematological values in children with sickle cell disease from Georgia.Am J Hematol. 1987 Aug;25(4):389-400. doi: 10.1002/ajh.2830250405. Am J Hematol. 1987. PMID: 2441597
-
Alpha thalassemia and the hematology of homozygous sickle cell disease in childhood.Blood. 1986 Feb;67(2):411-4. Blood. 1986. PMID: 2417644
-
The red cell distribution width in sickle cell disease--is it of clinical value?Clin Lab Haematol. 1991;13(3):229-37. doi: 10.1111/j.1365-2257.1991.tb00277.x. Clin Lab Haematol. 1991. PMID: 1794225
-
Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease.Blood. 1995 Jul 15;86(2):776-83. Blood. 1995. PMID: 7606007 Review.
-
Not all red cells sickle the same: Contributions of the reticulocyte to disease pathology in sickle cell anemia.Blood Rev. 2020 Mar;40:100637. doi: 10.1016/j.blre.2019.100637. Epub 2019 Nov 5. Blood Rev. 2020. PMID: 31735458 Free PMC article. Review.
Cited by
-
The protective effect of the spleen in sickle cell patients. A comparative study between patients with asplenia/hyposplenism and hypersplenism.Front Physiol. 2022 Aug 29;13:796837. doi: 10.3389/fphys.2022.796837. eCollection 2022. Front Physiol. 2022. PMID: 36105295 Free PMC article.
-
A clinically meaningful fetal hemoglobin threshold for children with sickle cell anemia during hydroxyurea therapy.Am J Hematol. 2017 Dec;92(12):1333-1339. doi: 10.1002/ajh.24906. Epub 2017 Sep 28. Am J Hematol. 2017. PMID: 28913922 Free PMC article.
-
Morphological and functional platelet abnormalities in Berkeley sickle cell mice.Blood Cells Mol Dis. 2008 Jul-Aug;41(1):109-18. doi: 10.1016/j.bcmd.2008.01.008. Epub 2008 Apr 18. Blood Cells Mol Dis. 2008. PMID: 18374611 Free PMC article.
-
Hematopoietic cell transplantation for sickle cell disease: updates and future directions.Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):181-189. doi: 10.1182/hematology.2021000251. Hematology Am Soc Hematol Educ Program. 2021. PMID: 34889368 Free PMC article.
-
Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure.Blood. 2012 Apr 19;119(16):3684-90. doi: 10.1182/blood-2011-05-349621. Epub 2011 Nov 17. Blood. 2012. PMID: 22096242 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical